Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

489 Press Releases
DateTitleCompany
01 Oct 10 Merck to Hold Third-Quarter 2010 Sales and Earnings Conference Call on Oct. 29 Merck & Co. Inc.,
Published by
Business Wire
01 Oct 10 Merck to Appeal Verdict in Massachusetts Medicaid Case Merck & Co. Inc.,
Published by
Business Wire
29 Sep 10 ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) Awarded Prix Galien USA 2010 Top Honor Merck,
Published by
Business Wire
22 Sep 10 Merck Significantly Expands its Patient Assistance Program Offerings to Provide Access to More Medicines for People in Need Merck,
Published by
Business Wire
16 Sep 10 Merck's Non-Profit to Advance Science Education Joins President Obama's Educate to Innovate Campaign Merck,
Published by
Business Wire
02 Sep 10 BRINAVESS™ (vernakalant) for Infusion Approved in the European Union for Rapid Conversion of Recent Onset Atrial Fibrillation Merck and Cardiome Pharma Corp.,
Published by
Business Wire
24 Aug 10 Merck Provides New Funding to Fight HIV/AIDS in Botswana Merck,
Published by
Business Wire
13 Aug 10 Merck Announces Mandatory Conversion of its 6.00% Mandatory Convertible Preferred Stock Merck & Co. Inc.,
Published by
Business Wire
04 Aug 10 In Pivotal Phase III Studies, Merck’s Investigational Medicine Boceprevir Helped Majority of Patients with Chronic Hepatitis C Genotype 1 Infection Achieve Sustained Virologic Response, the Primary Endpoint of the Studies Merck,
Published by
Business Wire
30 Jul 10 Merck Announces Second-Quarter 2010 Financial Results Merck & Co. Inc.,
Published by
Business Wire
28 Jul 10 Merck Grants License to LabCorp for Development of Test To Potentially Identify Patients Likely to Respond to Hepatitis C Therapy Merck,
Published by
Business Wire
28 Jul 10 Merck Announces Fourth-Quarter 2010 Dividend Merck & Co. Inc.,
Published by
Business Wire
27 Jul 10 Sinopharm and Merck Sign Statement of Mutual Intent Merck,
Published by
Business Wire
27 Jul 10 Sanofi-aventis and Merck Appoint Raul Kohan as CEO for the New Animal Health Joint Venture Merck & Co. Inc.,
Published by
Business Wire
09 Jul 10 Merck Details Plans to Advance Integration of R&D, Manufacturing and Business Operations Worldwide Merck,
Published by
PharmiWeb.com
08 Jul 10 Merck Details Plans to Advance Integration of R&D, Manufacturing and Business Operations Worldwide Merck & Co. Inc.,
Published by
Business Wire
01 Jul 10 Merck Serono: Survey Shows the Number of mCRC Patients Tested for KRAS Jumped 50% in 12 Months Merck Serono,
Published by
Business Wire
30 Jun 10 Merck to Hold Second-Quarter 2010 Sales and Earnings Conference Call on July 30 Merck & Co. Inc.,
Published by
Business Wire
30 Jun 10 Merck Wins Case Filed by Louisiana Attorney General Involving VIOXX® Merck & Co. Inc.,
Published by
Business Wire
29 Jun 10 Merck Serono To Award Grant To Innovative Research Projects In Fertility Merck Serono,
Published by
PharmiWeb.com
28 Jun 10 Findings From Global Survey Help Understand Fertility Trends And Barriers to Seeking Medical Help Against Infertility Merck Serono S A,
Published by
PR Newswire
28 Jun 10 In a Post-Hoc Analysis, JANUVIA® (sitagliptin), Merck’s Diabetes Medicine, Compared with a Sulfonylurea (Glipizide) on Composite Endpoint of Lower Blood Sugar, No Hypoglycemia and No Weight Gain Merck & Co. Inc.,
Published by
Business Wire
28 Jun 10 Investigational BRINAVESS® (vernakalant) for Infusion Recommended for Approval by the CHMP in the European Union (EU) for the Rapid Conversion of Recent Onset Atrial Fibrillation Merck,
Published by
Business Wire
28 Jun 10 In Pan-European Survey, Four out of Five Women Attempting to Conceive Wish They Had Visited a Fertility Specialist Sooner Merck,
Published by
Business Wire
26 Jun 10 In a New Study, Treatment With JANUMET® (sitagliptin/metformin), Merck's Diabetes Medicine, Resulted In Significantly Greater Blood Sugar Lowering Compared with Pioglitazone Merck,
Published by
Business Wire
26 Jun 10 Merck Challenges Verdict in Federal FOSAMAX® (alendronate sodium) Trial Merck & Co. Inc.,
Published by
Business Wire
25 Jun 10 Committee for Medicinal Products for Human Use (CHMP) Issues Opinion on European Regulatory Filing for Merck's Atypical Antipsychotic Medication SYCREST® (asenapine) Merck & Co. Inc.,
Published by
Business Wire
25 Jun 10 Investigational BRINAVESS™ (vernakalant) for Infusion Recommended for Approval by the CHMP in the European Union (EU) for the Rapid Conversion of Recent Onset Atrial Fibrillation Merck,
Published by
Business Wire
25 Jun 10 Merck Serono Calls for Entries to Real MS - Your Story, a Global Competition to Raise Awareness of Multiple Sclerosis Merck Serono S A,
Published by
PR Newswire
24 Jun 10 FDA Approves Merck's DULERA® (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older Merck,
Published by
Business Wire
Advertising